Home / Inspections / 1239106

FDA Inspection 1239106 — InfoRLife SA

InfoRLife SA — FEI 3004537783

The FDA completed an inspection of InfoRLife SA on May 3, 2024 in Campascio. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 3, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Campascio (Switzerland)

Facility

Other inspections at this facility

  • 1107436 (NAI Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1044861 (NAI Fri Feb 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 989892 (NAI Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 841082 (NAI Thu Jul 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 719827 (VAI Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources